Page last updated: 2024-08-26

lopinavir and Viremia

lopinavir has been researched along with Viremia in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (44.44)29.6817
2010's15 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernández Cooke, E; Holguín, Á; Jiménez De Ory, S; Navarro, ML; Prieto, L; Ramos, JT; Rojas Sánchez, P1
Bacchetti, P; Gandhi, M; Horng, H; Jin, C; Kerr, S; Koss, CA; Kuncze, K; Louie, A; Phung, N; Pintye, J; Prasitsuebsai, W; Singtoroj, T; Sohn, AH; Teeraananchai, S1
Blanco, J; Clotet, B; Gómez-Mora, E; Hernández-Rodríguez, A; Marfil, S; Martínez-Bonet, M; Martinez-Picado, J; Matas, L; Moltó, J; Morón-López, S; Muñoz-Fernández, MA; Puertas, MC; Santos, JR; Urrea, V1
Boinett, R; Brooks, K; Buziba, N; Coetzer, M; DeLong, A; Diero, L; Emonyi, W; Hogan, J; Kantor, R; Kemboi, E; Obonge, S; Orido, M; Reitsma, M; Rono, M; Schreier, L1
Perelson, AS; Zhang, J1
Bosch, RJ; Eron, JJ; Kuritzkes, DR; Taiwo, B; Vardhanabhuti, S1
Hull, MW; Lima, VD; Montaner, JS; Richard Harrigan, P; Sierra-Madero, J; Singer, J; Wood, E; Wu, Z1
Arribas, JR; Bernardino, JI; Estébanez, M; González-García, JJ; Mingorance, J; Montes, ML; Pérez-Valero, I; Stella-Ascariz, N; Zamora, FX1
Haagmans, BL; Koopmans, MP; Koulouris, NG; Koutsoukou, A; Osterhaus, AD; Pontikis, K; Raj, VS; Spanakis, N; Tsakris, A; Tsiodras, S1
Abrams, EJ; Castel, S; Coovadia, A; Kuhn, L; Maartens, G; McIlleron, H; Moholisa, RR; Patel, F; Pinillos, F; Schomaker, M; Strehlau, R; Wiesner, L1
Andreoni, M; Antinori, A; Castagna, A; Ceccherini-Silberstein, F; Celesia, BM; Cozzi-Lepri, A; d'Arminio Monforte, A; De Luca, A; Galli, M; Gianotti, N; Mussini, C; Pinnetti, C; Spagnuolo, V1
Llenas-García, J; Pulido Ortega, F1
Delgado, R1
Pacios, E1
Andrade-Villanueva, J; Barnard, RJ; Berger, DS; Cooper, DA; Dejesus, E; Dinubile, MJ; Eron, JJ; Fätkenheuer, G; Kumar, PN; Leavitt, R; Miller, MD; Nguyen, BY; Rodgers, AJ; Shaughnessy, MA; Sklar, P; Walker, ML; Workman, C; Xu, X; Youle, M; Young, B; Zajdenverg, R1
Abrams, EJ; Coovadia, A; Hu, CC; Hunt, G; Kuhn, L; Martens, L; Meyers, T; Morris, L; Sherman, G; Stehlau, R; Tsai, WY1
D'Avolio, A; Fuchs, D; Gisslén, M; Hagberg, L; Svennerholm, B; Verhofstede, C; Watson, V; Yilmaz, A1
Dunn, DT; Gibb, DM; Gilks, CF; Kaleebu, P; Kasirye, R; Kikaire, B; Mambule, I; Musana, H; Pillay, D; Reid, A; Robertson, V; Spyer, M; Ssali, F; Walker, AS; Yirrell, D1
Fusco, G; Liao, Q; Paulsen, D; Ross, L; Shaefer, M; St Clair, M1
Albert, J; Blaxhult, A; Brandin, E; Broström, C; Gisslen, M; Gyllensten, K; Hagberg, L; Lindborg, L; Tuvesson, B1
Adorni, F; Bini, T; Bongiovanni, M; Capetti, A; Cargnel, A; Chiesa, E; Cicconi, P; Cordier, L; d'Arminio Monforte, A; Landonio, S; Meraviglia, P; Rusconi, S; Tordato, F1
Adorni, F; Bini, T; Bongiovanni, M; Chiesa, E; Cicconi, P; Monforte d'Arminio, A1
Dalmau, D; Ferrer, E; Gatell, JM; Iniguez, D; Knobel, H; Leon, A; Niubo, J; Podzamczer, D; Polo, C; Ruiz, I1
Arribas, JR; Delgado, R; McKinnon, JE; Mellors, JW; Pulido, F1
Amoroso, A; Chan-Tack, KM; Kopack, AM; Polk, C1
Hanna, GJ; Podsadecki, TJ; Rode, RA; Tousset, EP; Vrijens, BC1
Bay, MB; Jeffman, MW; Lazzaretti, RK; Mattevi, VS; Sprinz, E1

Reviews

2 review(s) available for lopinavir and Viremia

ArticleYear
[Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV-1 infection].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 16

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Cost Control; Developing Countries; Drug Combinations; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Multicenter Studies as Topic; Pilot Projects; Prospective Studies; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Treatment Outcome; Viral Load; Viremia; Virus Replication

2008
[Lopinavir/ritonavir monotherapy for the treatment of HIV-1 infection: the emergence of resistance].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 16

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Multiple, Viral; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Lopinavir; Mutation, Missense; Pilot Projects; Point Mutation; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Viremia

2008

Trials

10 trial(s) available for lopinavir and Viremia

ArticleYear
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.
    The Journal of antimicrobial chemotherapy, 2018, 07-01, Volume: 73, Issue:7

    Topics: Adult; Antiretroviral Therapy, Highly Active; Darunavir; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunity, Cellular; Inflammation; Lopinavir; Lymphocyte Activation; Male; Middle Aged; Pilot Projects; Proof of Concept Study; Raltegravir Potassium; RNA, Viral; Viremia; Virus Replication

2018
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years.
    Journal of the International AIDS Society, 2014, Volume: 17

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Treatment Outcome; Viral Load; Viremia

2014
Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study.
    BMC infectious diseases, 2014, Jul-10, Volume: 14

    Topics: Adult; Biomarkers; Cross-Sectional Studies; Cytokines; Darunavir; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Inflammation; Lopinavir; Male; Middle Aged; Ritonavir; Sulfonamides; Viremia

2014
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.
    Lancet (London, England), 2010, Jan-30, Volume: 375, Issue:9712

    Topics: Adult; Anti-HIV Agents; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Pyrrolidinones; Raltegravir Potassium; Ritonavir; RNA, Viral; Treatment Outcome; Viremia

2010
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.
    JAMA, 2010, Sep-08, Volume: 304, Issue:10

    Topics: Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Maternal Exposure; Nevirapine; Protease Inhibitors; Pyrimidinones; RNA, Viral; Stavudine; Treatment Outcome; Viremia

2010
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2010, Dec-15, Volume: 55, Issue:5

    Topics: Adult; Albumins; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Central Nervous System Infections; Cross-Over Studies; Cyclohexanes; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Immunoglobulin G; Lopinavir; Male; Maraviroc; Middle Aged; Neopterin; Peptide Fragments; Polymerase Chain Reaction; Ritonavir; RNA, Viral; Triazoles; Viral Load; Viremia; Virus Replication

2010
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
    Antiviral therapy, 2012, Volume: 17, Issue:7

    Topics: Adult; Africa; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Mutation; Ritonavir; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Viremia

2012
Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutations.
    Antiviral therapy, 2003, Volume: 8, Issue:3

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Mutation; Proportional Hazards Models; Pyrimidinones; Ritonavir; Salvage Therapy; Viremia

2003
Early virological failure with a combination of tenofovir, didanosine and efavirenz.
    Antiviral therapy, 2005, Volume: 10, Issue:1

    Topics: Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Organophosphonates; Oxazines; Pyrimidinones; RNA, Viral; Tenofovir; Time Factors; Treatment Failure; Viremia

2005
Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia.
    The Journal of infectious diseases, 2007, Dec-15, Volume: 196, Issue:12

    Topics: Adult; Aged; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Prospective Studies; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Refusal; Viral Load; Viremia

2007

Other Studies

15 other study(ies) available for lopinavir and Viremia

ArticleYear
Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: Adolescent; CD4 Lymphocyte Count; CD4-CD8 Ratio; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance, Viral; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Lopinavir; Male; Mutation; Ritonavir; Spain; Treatment Outcome; Viral Load; Viremia

2017
Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy.
    Journal of acquired immune deficiency syndromes (1999), 2017, 12-01, Volume: 76, Issue:4

    Topics: Adolescent; Anti-HIV Agents; Asian People; CD4 Lymphocyte Count; Child; Drug Monitoring; Female; Hair; HIV Infections; Humans; Indonesia; Longitudinal Studies; Lopinavir; Male; Medication Adherence; Predictive Value of Tests; Thailand; Vietnam; Viral Load; Viremia

2017
HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.
    AIDS (London, England), 2018, 11-13, Volume: 32, Issue:17

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Kenya; Lopinavir; Male; Middle Aged; pol Gene Products, Human Immunodeficiency Virus; Ritonavir; Sequence Analysis, DNA; Treatment Failure; Viral Load; Viremia

2018
Contribution of follicular dendritic cells to persistent HIV viremia.
    Journal of virology, 2013, Volume: 87, Issue:14

    Topics: Dendritic Cells, Follicular; Drug Combinations; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Lopinavir; Models, Biological; Ritonavir; Stavudine; Viral Load; Viremia; Virus Release

2013
Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
    Antiviral therapy, 2015, Volume: 20, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Evolution, Molecular; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Phylogeny; pol Gene Products, Human Immunodeficiency Virus; Retrospective Studies; Ritonavir; RNA, Viral; Viral Load; Viremia

2015
Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:6

    Topics: Antiviral Agents; Coronavirus Infections; Drug Combinations; Drug Therapy, Combination; Greece; Humans; Lopinavir; Male; Middle East Respiratory Syndrome Coronavirus; Phylogeny; Respiratory Tract Infections; Ribavirin; Ritonavir; Viremia; Virus Shedding

2014
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:12

    Topics: Child, Preschool; Drug Monitoring; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Nevirapine; Treatment Outcome; Viral Load; Viremia

2016
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.
    PloS one, 2017, Volume: 12, Issue:2

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kaplan-Meier Estimate; Lopinavir; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Ritonavir; RNA, Viral; Viral Load; Viremia; Young Adult

2017
[Regimen simplification: lopinavir/ritonavir with or without efavirenz].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:9

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; Humans; Lopinavir; Pyrimidinones; Ritonavir; Treatment Outcome; Viral Load; Viremia

2009
Genotypic and phenotypic cross-resistance patterns to lopinavir and amprenavir in protease inhibitor-experienced patients with HIV viremia.
    AIDS research and human retroviruses, 2002, Sep-20, Volume: 18, Issue:14

    Topics: Carbamates; Cross-Sectional Studies; Drug Resistance, Viral; Furans; Genotype; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Microbial Sensitivity Tests; Mutation; Phenotype; Pyrimidinones; Retrospective Studies; RNA, Viral; Sulfonamides; Viremia

2002
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
    AIDS research and human retroviruses, 2003, Volume: 19, Issue:7

    Topics: Adolescent; Adult; Africa, Western; Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Codon; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Genes, pol; Genetic Variation; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Nelfinavir; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Sequence Alignment; Sequence Homology, Amino Acid; Sweden; Treatment Failure; Viremia; Zidovudine

2003
Lopinavir/ritonavir vs. indinavir/ritonavir in antiretroviral naive HIV-infected patients: immunovirological outcome and side effects.
    Antiviral research, 2004, Volume: 62, Issue:1

    Topics: Adult; Antiretroviral Therapy, Highly Active; Cholesterol; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lopinavir; Male; Pyrimidinones; Retrospective Studies; Ritonavir; RNA, Viral; Viremia

2004
The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone.
    AIDS (London, England), 2006, Nov-28, Volume: 20, Issue:18

    Topics: Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Longitudinal Studies; Lopinavir; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Treatment Failure; Viral Load; Viremia

2006
Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection.
    AIDS patient care and STDs, 2007, Volume: 21, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine; Enfuvirtide; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Lopinavir; Male; Organophosphonates; Peptide Fragments; Pyrimidinones; Ritonavir; Tenofovir; Viral Load; Viremia

2007
Lopinavir/ritonavir monotherapy as maintenance treatment in HIV-infected individuals with virological suppression: results from a pilot study in Brazil.
    HIV medicine, 2008, Volume: 9, Issue:5

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Brazil; CD4 Lymphocyte Count; Cytochrome P-450 CYP3A; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pilot Projects; Polymorphism, Genetic; Pyrimidinones; Ritonavir; RNA, Viral; Viral Load; Viremia

2008